S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1|
|Isis Pharmaceuticals Earns $7.5 Million Milestone Payment From AstraZeneca|
|Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy|
|Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award|
|Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer|
|Isis Pharmaceuticals to Present at Upcoming Investor Conferences|
|Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics|
|Isis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2014 (2014/11/7)|
|AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods|
|Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery (2014/12/7)|
Click above to view more mutual fund data and stats for isis - Isis Pharmaceuticals.